MDGL

Madrigal Pharmaceuticals, Inc. $540.06 1M +6.4% 3M +12.3% YTD -9.1% as of 2026-09-14
+Watchlist

next ticker · + or scroll to zoom · pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  ·  moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.7%
Next 1 week
+0.9%
Next 1 month
-0.3%
Seasonality
Mildly positive window
Next 30 days (to Oct 15): +0.5% median, 50% of the last 18 years finished up.
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 67
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.32%/day.
Mean-reversion stats →
1-month breakdown — Market · β 0.33 -0.2% · Seasonal tilt -0.1%
$117M/day volume 44% volatility +23% 1-year -12% from ATH
52-week range · 66% of the way up · -12% from the high
$393.61$615.00

Congressional trades in MDGL Full tracker →

1 member · 0 buys / 1 sells · $1K–$15K disclosed · latest filing May 19, 2023.

SELL DG Daniel Goldman · traded Apr 10, 2023 $1K–$15K

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.